If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email publications@phe.gov.uk.
Please tell us what format you need. It will help us if you say what assistive technology you use.

If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email publications@phe.gov.uk.
Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This PGD template was developed in 2015 for use in incidents involving avian influenza strains other than avian influenza A H5N8 and H7N9. The template is to support the supply of oseltamivir for pre and post exposure prophylaxis (PEP) of avian influenza as a public health measure in adults and children aged one year or older. It has been reviewed and updated in January 2018. It is valid from 1 February 2018 until 1 February 2021.

This PGD template was developed in 2017 due to revised interim recommendations adopted for this strain of avian influenza. The template is to support the supply of oseltamivir for post exposure prophylaxis of avian influenza A (H5N8) as a public health measure in adults and children aged one year or older. It has been reviewed and updated in January 2018. It is valid from 1 February 2018 until 1 February 2021.

Both PGD templates require further authorisation by a clinical governance or patient safety lead, who has designated responsibility for signing PGDs, so the documents meet legal requirements for PGDs. The PGDs are not legal or valid without this local, formal authorisation.

Adoption and governance of the use of these PGDs is the responsibility of the authorising commissioning body and providers.

Provider organisations and health professionals should check they are working to the current PGD versions and only work to a legally authorised PGD from their commissioning body.